MARKET

AVEO

AVEO

Aveo
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.6258
-0.0334
-5.07%
Closed 19:12 11/19 EST
OPEN
0.6662
PREV CLOSE
0.6592
HIGH
0.6662
LOW
0.6201
VOLUME
1.76M
TURNOVER
--
52 WEEK HIGH
2.250
52 WEEK LOW
0.4692
MARKET CAP
100.59M
P/E (TTM)
2.389
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of AVEO and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 3 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

AVEO News

  • AVEO Oncology Announces Appointment of Scarlett Spring to its Board of Directors
  • Business Wire.22h ago
  • Aveo Pharma up 4% on advancement of tivozanib
  • Seeking Alpha - Article.1d ago
  • AVEO Announces Presentation of Updated OS and Subgroup Data from Phase 3 TIVO-3 Trial of Tivozanib in Renal Cell Carcinoma
  • Benzinga.1d ago
  • AVEO Announces Presentation of Updated OS and Subgroup Data from Phase 3 TIVO-3 Trial of Tivozanib in Renal Cell Carcinoma
  • Business Wire.1d ago

More

Industry

Biotechnology & Medical Research
+2.16%
Pharmaceuticals & Medical Research
+0.78%

Hot Stocks

Name
Price
%Change

About AVEO

AVEO Pharmaceuticals, Inc. is a biopharmaceutical company. The Company's platform delivers insights into cancer and related disease. The Company's product candidates include Tivozanib, Ficlatuzumab, AV-203 and AV-380. Tivozanib is a selective long half-life vascular endothelial growth factor tyrosine kinase inhibitor (VEGF TKI) that inhibits over three VEGF receptors. Tivozanib is designed to optimize VEGF blockade while minimizing off-target toxicities. Ficlatuzumab is a Hepatocyte Growth Factor (HGF) inhibitory antibody. AV-203 is an anti-ErbB3 monoclonal antibody with ErbB3 affinity. Its preclinical studies suggest that neuregulin1 (NRG1) levels predict AV-203 antitumor activity in preclinical models. AV-380 is a humanized Immunoglobulin G 1 (IgG1) inhibitory monoclonal antibody. AV-380 targets growth differentiating factor 15 (GDF15).
More

Webull offers AVEO Pharmaceuticals, Inc. (AVEO) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.